Tactile Systems TechnologyFRA:3L3 -0.53%76 EBITDA Margin % is 1.02% as of Mar. 2026, which is 82% below its 10-year median of 5.61. GuruFocus rates FRA:3L3 with a GF Score™ of 76/100 and a GF Value™ of €16.59 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Tactile Systems Technology ranks better than 59.56% on this metric.
Tactile Systems Technology (FRA:3L3) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Tactile Systems Technology EBITDA Margin % Related Terms
Tactile Systems Technology EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:3L3 vs SSII, BVS, BBNX: EBITDA Margin % Comparison
For the Medical Devices subindustry, Tactile Systems Technology's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tactile Systems Technology EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Tactile Systems Technology's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Tactile Systems Technology's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tactile Systems Technology (FRA:3L3) has a EBITDA Margin % of 1.02% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Tactile Systems Technology and its competitors. This is 82% below median its historical median of 5.61. According to the industry distribution chart, Tactile Systems Technology ranks #330 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 40.4%.
Is Tactile Systems Technology's EBITDA Margin % too high?
Tactile Systems Technology's current EBITDA Margin % of 1.02% is 82% below median its 10-year median of 5.61. The Medical Devices & Instruments industry median EBITDA Margin % is 7.46. Tactile Systems Technology's value of 1.02% is 86.3% below this industry median. Based on the distribution chart, Tactile Systems Technology ranks #330 out of 816 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Tactile Systems Technology has a GF Score™ of 76/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Tactile Systems Technology's EBITDA Margin % compare to SSII and BVS?
According to the Medical Devices & Instruments industry distribution chart, Tactile Systems Technology ranks #330 out of 816 companies for EBITDA Margin %. This puts Tactile Systems Technology in the upper half of its industry. The industry median EBITDA Margin % is 7.46. Tactile Systems Technology's value of 1.02% is 86.3% below this benchmark. While the company's 10-year median is 5.61 vs. the industry median of 7.46, Tactile Systems Technology has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.46, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tactile Systems Technology's current EBITDA Margin % of 1.02% is 86.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Tactile Systems Technology and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tactile Systems Technology's current EBITDA Margin % is 1.02%, which is 82% below median its own 10-year median of 5.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tactile Systems Technology stock overvalued right now?
Based on GuruFocus' analysis, Tactile Systems Technology (FRA:3L3) is currently considered Significantly Overvalued. The stock's GF Value™ is €16.59, compared to a current price of €26.42 — trading 59.3% above its estimated fair value. The current EBITDA Margin % is 1.02%, which is 82% below median its 10-year median of 5.61 and 86.3% below the Medical Devices & Instruments industry median of 7.46. Tactile Systems Technology's overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Tactile Systems Technology (FRA:3L3), the current EBITDA Margin % is 1.02% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tactile Systems Technology (FRA:3L3) Overvalued in 2026?
Based on GuruFocus' analysis, Tactile Systems Technology stock appears to be overvalued.
The current stock price of €26.42 is trading 59.3% above its estimated GF Value™ of €16.59.
GuruFocus considers Tactile Systems Technology to be Significantly Overvalued.
Key valuation signals for FRA:3L3:
EBITDA Margin %: 1.02% (82% below median its 10-year median of 5.61)
GF Value™: €16.59 vs. price of €26.42 (59.3% above fair value)
Industry Position: 86.3% below the Medical Devices & Instruments median (#330 of 816)
No single metric tells the full story. See the FRA:3L3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system, provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.
76GF Score
Get the complete analysis for FRA:3L3
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:3L3 has been successfully added to your 
